Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-807-2013

Drug recall · July 24, 2013

Medroxyprogesterone acetate recall

Why: Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin

Lots / codes

Lot 87100040

Quantity
194.62 kg
Company
Bayer HealthCare Pharmaceuticals Inc., Morristown, NJ
Distribution
NY, CA
Initiated
June 13, 2013 · Voluntary: Firm initiated
Classified
July 18, 2013
Reported
July 24, 2013
Ended
February 10, 2014
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Medroxyprogesterone

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.